MyStart Health is a newer ultra-budget GLP-1 platform, while Shed reports 150,000+ members and advertises a 120-day money-back guarantee if you do not lose 5% of your weight, subject to eligibility, required check-ins and adherence to the program. This comparison examines whether the savings are worth the trade-offs.
Platform Overview
MyStart Health is a newer GLP-1 telehealth platform that entered the market in 2023, offering budget-accessible weight loss programs at $149-$299 per month. The platform positions itself as an accessible entry point for patients who are new to GLP-1 therapy and want a lower-cost starting point before committing to higher-priced programs. MyStart Health is still building its clinical track record and provider network, which is typical for newer market entrants. The platform provides semaglutide and tirzepatide access through standard telehealth prescribing workflows, following FDA-established GLP-1 treatment protocols. Its lower pricing reflects both newer-platform competitive positioning and a leaner support infrastructure.
Shed is an established GLP-1 weight loss specialist with a proven program model operating at $199-$499 per month. Shed also advertises a conditional 120-day money-back guarantee (lose 5% of your weight or get a refund, subject to eligibility and program adherence). The
CDC's weight management research supports the type of structured, coaching-integrated program that Shed has built. If you are comparing a newer platform with a more established specialist, track record and refund terms are relevant differentiators.
Pricing Comparison
MyStart Health's $149-$299 per month pricing is among the most affordable in the GLP-1 telehealth market, with entry-level plans accessible to patients who might otherwise be priced out of telehealth weight loss programs. The lower floor reflects the platform's positioning as a budget-accessible option, though the specific support features at each price tier should be carefully evaluated. MyStart Health does not advertise a weight loss guarantee, and as a newer platform, it has a shorter track record for patients to evaluate. The
NIH's treatment access research acknowledges that cost is a significant barrier to GLP-1 treatment initiation for many patients.
Shed's $199-$499 pricing is higher than MyStart Health's floor but includes dedicated coaching and a 120-day refund term if you do not lose 5% of your weight, with eligibility, check-in and adherence conditions, which MyStart Health does not offer. The $50 entry-level price difference between the platforms is modest. If you can absorb a modest premium, Shed's coaching and refund term are what the extra cost buys.
Medication Options and Quality
MyStart Health offers semaglutide and tirzepatide through compounding pharmacy channels, consistent with the standard GLP-1 telehealth model. As a newer platform, patients should verify the specific compounding pharmacy partnerships and quality standards in use, as the track record for quality consistency is shorter than established platforms. The clinical prescribing protocols follow standard GLP-1 titration guidelines, and licensed providers handle all prescription decisions.
NEJM semaglutide trial data shows strong efficacy when medication quality and dosing are properly managed, making pharmacy quality verification important for any compounding-based platform.
Shed provides semaglutide and tirzepatide through established compounding pharmacy relationships with a clinical management layer that monitors dosing, tolerability, and progress as part of the broader program. The platform's medication protocols are integrated with its coaching program, so adjustments are made in coordination with behavioral support rather than as isolated clinical decisions. Tirzepatide's superior efficacy - with
NEJM data showing 20%+ average weight loss - is available to qualifying Shed patients. Shed's longer operating track record means its pharmacy relationships and quality protocols are more thoroughly established.
Medical Team and Support
MyStart Health provides licensed medical oversight for GLP-1 prescribing, with the clinical model focused primarily on medication management. As a newer, budget-positioned platform, the depth of coaching and behavioral support available is limited compared to established specialist platforms. The provider network is still growing, which can affect response times and continuity of care. Patients seeking a lower-cost entry point to GLP-1 therapy who are comfortable with minimal support may find MyStart Health adequate, but those who need structured behavioral coaching will likely outgrow the platform's support level quickly. JAMA research consistently links support intensity to long-term outcomes.
Shed's weight loss coaching model provides behavioral support that extends well beyond what budget or newer platforms typically offer. Coaches at Shed are central to the patient experience, providing proactive check-ins, goal-setting sessions, and adherence support throughout the program lifecycle. The clinical oversight is provided by licensed physicians and nurse practitioners, ensuring appropriate medical management alongside the behavioral programming. The
American Association of Clinical Endocrinology recommends this combined clinical and behavioral model as the evidence-based standard for GLP-1 obesity treatment.
Weight Loss Approach and Programs
MyStart Health's weight loss approach centers on providing affordable GLP-1 access with basic clinical guidance, suited to patients who view the platform primarily as a prescribing pathway. The program includes standard dosing guidance and lifestyle recommendations, but the behavioral coaching depth and program structure are lighter than specialist platforms. For patients who are starting their GLP-1 journey and want to try a low-commitment, low-cost option first, MyStart Health can serve as an initial entry point.
Shed pairs GLP-1 medication with coaching and a 120-day money-back guarantee if you do not lose 5% of your weight, subject to eligibility, required check-ins and adherence to the program. The program design integrates medication management with behavioral coaching, nutritional guidance, and regular progress monitoring. This full approach reflects the clinical consensus that GLP-1 medications are most effective when behavioral modification accompanies pharmacotherapy.
User Experience and Satisfaction
MyStart Health's user experience is functional and accessible, with a straightforward onboarding process and prescription management workflow. As a newer platform, the app and patient portal are still being refined based on patient feedback, and the user experience may not have the polish of platforms with longer product development cycles. Patients who prioritize low cost and straightforward medication access report satisfaction with MyStart Health's simplicity. Those who expect rich coaching, program tracking, and proactive provider outreach may find the experience less developed than they anticipated.
Shed's member portal reflects a purpose-built weight loss program organized around its coaching model. Progress tracking and coaching check-ins are integrated into the member portal. Reviewers describe the coaching team as responsive and proactive. The
NIH's research confirms that structured, accountable programs produce better long-term GLP-1 adherence than platforms where patients manage their own programs with minimal support.
How We Compared MyStart Health vs Shed
Our Comparison Methodology
This comparison is based on analysis of pricing structures and service models from both platforms.
Clinical Evidence: Weight loss treatment recommendations reference FDA-approved GLP-1 medication information (FDA Wegovy Label) and clinical efficacy data from The New England Journal of Medicine.
Pricing Analysis: Pricing reflects the rates last recorded in our provider database; providers change prices frequently, so confirm current pricing directly at checkout.
Service Verification: Platform capabilities, provider credentials, and service quality were evaluated through detailed review of service offerings.
This comparison is written by our own editorial team, and ManyTreatments is paid an affiliate commission by most of the providers listed here when you buy through a link on this page. Payment for placement, for a rating, or for a listing is not something we accept. What we will not claim is that commissions have never influenced anything, because that would be a statement about our own conduct we cannot evidence. Our goal is to provide evidence-based comparison to help you make informed weight loss treatment decisions.
Final Verdict: MyStart Health vs Shed
Choose MyStart Health if: You are a cost-constrained patient seeking the lowest possible entry price for GLP-1 treatment and are self-directed enough to manage your program with minimal coaching. MyStart Health's $149/month entry pricing makes GLP-1 access possible for patients who cannot afford higher-priced platforms.
Choose Shed if: You want an established GLP-1 program with coaching and a conditional money-back guarantee. Shed adds a conditional 120-day money-back guarantee (lose 5% of your weight or get a refund, subject to eligibility and program adherence) and a longer operating track record.
Bottom line: MyStart Health and Shed both provide legitimate GLP-1 access, but at very different support levels and track records. For patients whose primary constraint is cost, MyStart Health is a viable entry point. If you want clinical support, behavioral coaching and a refund term in one program, Shed is the more compelling choice despite the modest premium.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
